Neuphoria Therapeutics Inc. - Common Stock (NEUP) Institutional Ownership $5.53 +0.13 (+2.41%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP)CurrentInstitutional OwnershipPercentage15.90%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$57.60KNumber ofInstitutional Sellers(last 12 months)0 Get NEUP Insider Trade Alerts Want to know when executives and insiders are buying or selling Neuphoria Therapeutics Inc. - Common Stock stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Neuphoria Therapeutics Inc. - Common Stock Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2025 Cyndeo Wealth Partners LLC10,000$58K0.0%N/A0.569% 2/14/2025 Jane Street Group LLC13,311$46K0.0%N/A0.817% 2/14/2025 Lynx1 Capital Management LP45,806$157K0.1%N/A2.810% (Data available from 1/1/2016 forward) NEUP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NEUP shares? During the previous two years, the following institutional investors and hedge funds held shares of Neuphoria Therapeutics Inc. - Common Stock shares: Lynx1 Capital Management LP ($157K), and Cyndeo Wealth Partners LLC ($58K), Jane Street Group LLC ($46K).Learn more on NEUP's institutional investors. What percentage of Neuphoria Therapeutics Inc. - Common Stock stock is owned by institutional investors? 15.90% of Neuphoria Therapeutics Inc. - Common Stock stock is owned by institutional investors. Learn more on NEUP's institutional investor holdings. Which institutional investors have been buying Neuphoria Therapeutics Inc. - Common Stock stock? The following institutional investors have purchased Neuphoria Therapeutics Inc. - Common Stock stock in the last 24 months: Lynx1 Capital Management LP ($45.81K), Jane Street Group LLC ($13.31K), and Cyndeo Wealth Partners LLC ($10K). How much institutional buying is happening at Neuphoria Therapeutics Inc. - Common Stock? Institutional investors have bought a total of 69,117 shares in the last 24 months. This purchase volume represents approximately $57.60K in transactions. Related Companies NRXP Institutional Ownership BRNS Institutional Ownership SPRO Institutional Ownership BLUE Institutional Ownership LVTX Institutional Ownership DYAI Institutional Ownership FBLG Institutional Ownership KZR Institutional Ownership FGEN Institutional Ownership MRNS Institutional Ownership This page (NASDAQ:NEUP) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuphoria Therapeutics Inc. - Common Stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuphoria Therapeutics Inc. - Common Stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.